Amarin falls after CEO steps down

Amarin

04/06/2024 15:19

** Shares of drug developer Amarin Corp  AMRN.O  fall ~11%
to 76 cents 
    ** Co says Chief Executive Officer Patrick Holt has stepped
down to pursue other opportunities   
    ** Appoints current Executive Vice President Aaron Berg as
CEO  
    ** AMRN says Berg will focus on co's lead product, Vascepa,
which won U.S. approval in 2012 
    ** Vascepa was approved to lower high levels of
triglycerides — blood fat that can increase risk of heart
disease   
    ** Including session's moves, AMRN shares are down 10.3% YTD

 (Reporting by Mariam Sunny in Bengaluru)
 ((Mariam.ESunny@thomsonreuters.com;))